SEARCH

MEDIA PACK

NEWS

Current Edition

COVID-19

Pfizer’s COVID-19 vaccine is safe, effective in kids ages 5 to 11, setting up possible FDA nod

Amid the nationwide COVID-19 vaccination campaign, youngsters 11 and under have been ineligible for shots—even though millions are back in school. With new Pfizer data, …

26 October 2021 Regional News COVID-19 FDA

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

SEARCH

MENU

Current Edition

Pfizer’s COVID-19 vaccine is safe, effective in kids ages 5 to 11, setting up possible FDA nod

Journal for Clinical Studies